| Literature DB >> 29492296 |
Laura M Hack1,2, Alec L W Dick1, Nadine Provençal1.
Abstract
5-hydroxymethylcytosine (5hmC) is a recently re-discovered transient intermediate in the active demethylation pathway that also appears to play an independent role in modulating gene function. Epigenetic marks, particularly 5-methylcytosine, have been widely studied in relation to stress-related disorders given the long-lasting effect that stress has on these marks. 5hmC is a good candidate for involvement in the etiology of these disorders given its elevated concentration in mammalian neurons, its dynamic regulation during development of the central nervous system, and its high variability among individuals. Although we are unaware of any studies published to date examining 5 hmC profiles in human subjects who have developed a psychiatric disorder after a life stressor, there is emerging evidence from the animal literature that 5hmC profiles are altered in the context of fear-conditioning paradigms and stress exposure, suggesting a possible role for 5hmC in the biological underpinnings of stress-related disorders. In this review, the authors examine the available approaches for profiling 5hmC and describe their advantages and disadvantages as well as discuss the studies published thus far investigating 5hmC in the context of fear-related learning and stress exposure in animals. The authors also highlight the global versus locus-specific regulation of 5hmC in these studies. Finally, the limitations of the current studies and their implications are discussed.Entities:
Keywords: 5-hydroxymethylcytosine; 5hmC; 5hmC detection methods; fear-related learning; stress
Year: 2016 PMID: 29492296 PMCID: PMC5804530 DOI: 10.1093/eep/dvw016
Source DB: PubMed Journal: Environ Epigenet ISSN: 2058-5888
5hmC detection methods and advantages/disadvantages
| Type of detection | Method | Advantages | Disadvantages |
|---|---|---|---|
| Global | Antibody-based DNA dot-blot |
Rapid, simple, inexpensive Able to adapt to ELISA format for relative quantification |
Semi-quantitative at best Usually requires microgram quantities of starting DNA Affected by any non-specific antibody binding Requires stringent 5hmC antibody validation |
| IHC |
Able to visualize 5hmC at the level of a single cell, metaphase chromosomes, and across a tissue sample |
Semi-quantitative at best Quite sensitive to sample preparation Affected by any non-specific antibody binding Requires stringent 5hmC antibody validation | |
| TLC |
5hmC can be analyzed in different sequence contexts using different enzymes Total 5hmC can be quantified via nearest neighbor analysis |
Not quantitative by itself Radioactive isotopes are needed Requires large quantity of starting DNA | |
| HPLC-MS |
Most accurate method for global quantification of 5hmC Sensitive and accurate Quantitative with the use of reference compounds |
Relatively costly Necessitates expert knowledge, advanced equipment, and large quantities of DNA | |
| Locus specific | hMeDIP |
Does not require the use of specialized equipment |
Regions with high density may be overrepresented, while those with low 5hmC density may be underrepresented Enriches for CA and CT repeats Affected by any non-specific antibody binding Requires stringent 5hmC antibody validation |
| CMS immunoprecipitation |
May be completed in 3 days Less dependent on 5hmC density than 5-HmeDIP |
Antiserum against CMS is not commercially available | |
| Hydroxymethyl-selective biotin labeling and capture |
Highly sensitive and efficient |
Labeling and capture efficiency and specificity is significantly reduced by low starting material | |
| JBP1 5hmC pull-down |
All components are readily available or can be rapidly synthesized |
JBP1 protein is not commercially available Requires up to 2 weeks | |
| Single nucleotide |
Restriction enzyme-based approaches (e.g. Reduced Representation 5hmC Profiling using
|
Highly reproducible data |
Requires specific sequence context Reduced representation of all cytosines |
| Pvu-Seal-Seq |
High sensitivity Detection of low abundance 5hmC loci with reduced sequencing coverage |
Cannot quantify absolute levels of 5hmC Restriction digestion increases risk of false positives | |
| oxBS conversion C sequenced as T 5mC sequenced as C 5hmC sequenced as T |
Protocol can be completed in 2 days The agent used to chemically oxidize 5hmC is highly selective |
DNA damage and degradation by chemical oxidation and repeated bisulfite treatments needed for deamination Requires comparison to standard bisulfite sequencing for single-base resolution 5hmC profiles Requires deep sequencing coverage for high-confidence 5hmC identification | |
| TAB conversion C sequenced as T 5mC sequenced as T 5hmC sequenced as C |
Treatment involves less DNA damage than oxBS |
Requires highly active TET enzymes, which are unstable, difficult to purify, and expensive βGT is inefficient at glycosylating CpG dinucleotides, where 5hmC usually occurs Requires deep sequencing coverage for high-confidence 5hmC identification |